A Study of Abiraterone Acetate Plus Prednisone in Patients With Metastatic Castration-Resistant Prostate Cancer Who Have Failed Docetaxel-Based Chemotherapy

NCT01695135 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

214

Enrollment

INDUSTRY

Sponsor class

Conditions

Prostate Neoplasms

Interventions

DRUG: Abiraterone acetate
DRUG: Placebo
DRUG: Prednisone

Sponsor

Janssen Research & Development, LLC